Mealey's (November 26, 2018, 2:30 PM EST) -- SEATTLE — A Ninth Circuit U.S. Court of Appeals panel on Nov. 8 affirmed a jury verdict for the maker of a homeopathic treatment accused of selling nothing more than sugar pills on claims under California’s Consumer Legal Remedies Act (CLRA) and upheld the trial court’s refusal to hold a bench trial on claims under California’s unfair competition law (UCL), opining that the evidence provided was sufficient to allow a jury to conclude that the product actually treats the flu (Christopher Lewert, et al. v. Boiron Inc., et al., No. 17-56607, 9th Cir., 2018 U.S. App. LEXIS 31712)....